Ok, at risk of getting in trouble for being a bit too honest/realistic I have read this thread several times and can't help but respond.
First of all yes, I do think that some of the improvements have improved lifespan. There is no doubt our ability to manage infections better has prolonged life. Likewise, the increased availability and technology for transplants has helped extend life in the period that would otherwise be the 'end-stage'.
However I work with numbers and statistics for a career. And because of that we need to be careful as statistics only say what you want them to say. A median life exectancy of 36 (per cff) means that of those diagnosed with CF, 1/2 will die before 36 and 1/2 after 36. It makes NO estimate for any single person or group of persons.
While we still lose way too many in their 20's, a median of 36 is much better than it was a few decades ago, for several reasons.
Some of those are things such as Pulmozyme & Tobi; the introduction of the vest to improve the effectiveness of CPT; more agressive treatment of infections and complications; and increased options for tx (which alone can add years).
However, as I said statistics are not 100%. The reason I say this is that 20 years ago, only the most 'typical' cystics were diagnosed and thus the statistics were based primarily upon those with early symptoms and classic progression. With the increased awareness of CF, and the introduction of genetic testing, allowing for 'a-typical' or adult diagnoses, we have increased the CF population being used.
While I feel it is great that we are better able to identify and help ALL cystics, not just thoses dx'd as a baby, everytime someone is dx'd in their 30's or 40's we are adding someone who 20 years ago would have never been considered to have cf.
Unfortunately, in my opinion, this makes comparisons of a statistics on life-expectancy a poor determinant of progress in treatment so we must focus on the quality of life and providing the best we can. Ultimately, nobody knows how long any of us will live, so live each day like it is your last and have no regrets.
First of all yes, I do think that some of the improvements have improved lifespan. There is no doubt our ability to manage infections better has prolonged life. Likewise, the increased availability and technology for transplants has helped extend life in the period that would otherwise be the 'end-stage'.
However I work with numbers and statistics for a career. And because of that we need to be careful as statistics only say what you want them to say. A median life exectancy of 36 (per cff) means that of those diagnosed with CF, 1/2 will die before 36 and 1/2 after 36. It makes NO estimate for any single person or group of persons.
While we still lose way too many in their 20's, a median of 36 is much better than it was a few decades ago, for several reasons.
Some of those are things such as Pulmozyme & Tobi; the introduction of the vest to improve the effectiveness of CPT; more agressive treatment of infections and complications; and increased options for tx (which alone can add years).
However, as I said statistics are not 100%. The reason I say this is that 20 years ago, only the most 'typical' cystics were diagnosed and thus the statistics were based primarily upon those with early symptoms and classic progression. With the increased awareness of CF, and the introduction of genetic testing, allowing for 'a-typical' or adult diagnoses, we have increased the CF population being used.
While I feel it is great that we are better able to identify and help ALL cystics, not just thoses dx'd as a baby, everytime someone is dx'd in their 30's or 40's we are adding someone who 20 years ago would have never been considered to have cf.
Unfortunately, in my opinion, this makes comparisons of a statistics on life-expectancy a poor determinant of progress in treatment so we must focus on the quality of life and providing the best we can. Ultimately, nobody knows how long any of us will live, so live each day like it is your last and have no regrets.